These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16698035)

  • 21. [Mapping of BRCT1 domain of BRCA1 with chromatin unfolding activity].
    Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
    Sheng Wu Gong Cheng Xue Bao; 2002 Nov; 18(6):656-61. PubMed ID: 12674632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.
    Campbell SJ; Edwards RA; Glover JN
    Structure; 2010 Feb; 18(2):167-76. PubMed ID: 20159462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Isolation and characterization of a BRCA1-interacting protein].
    Yan JH; Ye QN; Zhu JH; Zhong HJ; Zheng HY; Huang CF
    Yi Chuan Xue Bao; 2003 Dec; 30(12):1161-6. PubMed ID: 14986435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
    Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH
    J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer predisposing mutations in BRCT domains.
    di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
    IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of the N-terminal region of human Topoisomerase IIβ binding protein 1.
    Huo YG; Bai L; Xu M; Jiang T
    Biochem Biophys Res Commun; 2010 Oct; 401(3):401-5. PubMed ID: 20858457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.
    Yamane K; Katayama E; Tsuruo T
    Oncogene; 2001 May; 20(23):2859-67. PubMed ID: 11420698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-dependent BRCA1 cleavage facilitates chemotherapy-induced apoptosis.
    Dizin E; Ray H; Suau F; Voeltzel T; Dalla Venezia N
    Apoptosis; 2008 Feb; 13(2):237-46. PubMed ID: 18071904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.
    Shen Y; Tong L
    Biochemistry; 2008 May; 47(21):5767-73. PubMed ID: 18452305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV; Nominé Y; Yu X; Juranic N; Macura S; Chen J; Mer G
    Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q; Jubb H; Blundell TL
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):143-148. PubMed ID: 25701377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a carboxy-terminal BRCA1 interacting protein.
    Wong AK; Ormonde PA; Pero R; Chen Y; Lian L; Salada G; Berry S; Lawrence Q; Dayananth P; Ha P; Tavtigian SV; Teng DH; Bartel PL
    Oncogene; 1998 Nov; 17(18):2279-85. PubMed ID: 9811458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.
    Yamane K; Katayama E; Tsuruo T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):678-84. PubMed ID: 11118345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
    Derbyshire DJ; Basu BP; Serpell LC; Joo WS; Date T; Iwabuchi K; Doherty AJ
    EMBO J; 2002 Jul; 21(14):3863-72. PubMed ID: 12110597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression.
    Yu X; Wu LC; Bowcock AM; Aronheim A; Baer R
    J Biol Chem; 1998 Sep; 273(39):25388-92. PubMed ID: 9738006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants.
    Di Cecco L; Melissari E; Mariotti V; Iofrida C; Galli A; Guidugli L; Lombardi G; Caligo MA; Iacopetti P; Pellegrini S
    Eur J Cancer; 2009 Aug; 45(12):2187-96. PubMed ID: 19493677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage.
    Li S; Chen PL; Subramanian T; Chinnadurai G; Tomlinson G; Osborne CK; Sharp ZD; Lee WH
    J Biol Chem; 1999 Apr; 274(16):11334-8. PubMed ID: 10196224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites.
    Wu Q; Paul A; Su D; Mehmood S; Foo TK; Ochi T; Bunting EL; Xia B; Robinson CV; Wang B; Blundell TL
    Mol Cell; 2016 Feb; 61(3):434-448. PubMed ID: 26778126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.